Neurocrine Biosciences NBIX
$150.57 −$6.02 (-3.84%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $150.57 0.00%
Open$156.27
Prev close$156.59
Day range$150.24 – $158.26
Volume1.59M
Market cap$15.24B
P/E (TTM)22.3
Dividend yield–
Analyst view
ConsensusBuy
Analysts19
Average target$207.35+37.7% vs. price
- Buy 84%
- Hold 16%
Low $150.00Now $150.57Avg $207.35High $253.00
Recent rating changes
The last 20 actions on file set price targets from $150.00 to $230.00, averaging $199.61.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | Morgan Stanley | HOLD | $191.00 |
| 3 Nov 2026 | TD Cowen | BUY | $220.00 |
| 3 Nov 2026 | CCORF | BUY | $220.00 |
| 3 Nov 2026 | Wells Fargo | BUY | $200.00 |
| 3 Nov 2026 | Bernstein | BUY | $218.00 |
| 3 Nov 2026 | Piper Sandler | BUY | $215.00 |
| 3 Nov 2026 | BofA Securities | BUY | – |
| 3 Nov 2026 | Wedbush | BUY | $186.00 |
| 3 Nov 2026 | Morgan Stanley | HOLD | $185.00 |
| 3 Nov 2026 | Deutsche Bank | HOLD | $175.00 |
| 3 Nov 2026 | Guggenheim | BUY | $224.00 |
| 3 Nov 2026 | Oppenheimer | BUY | $230.00 |
| 2 Nov 2026 | Cantor Fitzgerald | BUY | $215.00 |
| 2 Nov 2026 | Morgan Stanley | HOLD | $183.00 |
| 2 Nov 2026 | BMO Capital | HOLD | $150.00 |
| 2 Nov 2026 | RBC Capital | BUY | $190.00 |
| 2 Nov 2026 | J.P. Morgan | BUY | – |
| 16 Oct 2026 | Needham | BUY | $204.00 |
| 13 Oct 2026 | Wells Fargo | BUY | $200.00 |
| 13 Oct 2026 | RBC Capital | BUY | $187.00 |
No comments yet — be the first to weigh in on NBIX.
Sign in to join the discussion.